Items where authors include "Bertelli, G"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Glasbey, JC, Nepogodiev, D, Omar, O et al. (3453 more authors) (2020) Delaying surgery for patients with a previous SARS-CoV-2 infection. British Journal of Surgery, 107 (12). e601-e602. ISSN 0007-1323

Hall, M, Bertelli, G, Li, L et al. (7 more authors) (2020) Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study. International Journal of Gynecological Cancer, 30 (2). pp. 213-220. ISSN 1048-891X

Coleman, RE, Collinson, M orcid.org/0000-0003-3568-6455, Gregory, W orcid.org/0000-0003-2641-8416 et al. (20 more authors) (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). Journal of Bone Oncology, 13. pp. 123-135. ISSN 2212-1374

Brown, J, Rathbone, E, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Morden, JP, Alvarez, I, Bertelli, G et al. (18 more authors) (2017) Long-Term Follow-Up of the Intergroup Exemestane Study. Journal of Clinical Oncology, 35 (22). pp. 2507-2514. ISSN 0732-183X

Cameron, D, Morden, JP, Canney, P et al. (21 more authors) (2017) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 18 (7). pp. 929-945. ISSN 1470-2045

This list was generated on Sat Mar 23 07:13:36 2024 GMT.